Data on naptumomab estafenatox enhancing CAR-T cells potency

Lund, Sweden - November 30, 2021 - Active Biotech and its partner NeoTX announced that the preclinical data on naptumomab enhancing the potency of CAR-T cells was presented on Nov 12th at the Society for

Related Keywords

Sweden , Stockholm , Washington , United States , Hans Kolam , Society For Immunotherapy Of Cancer , Waltere Washington Convention Center , Nasdaq , Biotech To Neotx Therapeutics Ltd , Annual Meeting , Convention Center , Active Biotech , Tumor Targeted Superantigen , Data , Aptumomab , Stafenatox , Nhancing , Cells , Potency , Resented , Ctive , Biotech , Partner , Neotx , Itc , 021 ,